Decomit Nasal Spray 200MD

100411200300101

Decomit Nasal Spray 200MD

146.00৳ 

Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)

Description

Indications of Decomit Nasal Spray

Beclometasone 50, 100 & 250 HFA Inhaler is shown within the prophylactic administration of mellowdirect, or extreme asthma in grown-ups or children. Beclometasone dipropionate given by inward breath offers preventative treatment for asthma. It provides effective anti-inflammatory activity within the lungs with a lower rate and seriousness of antagonistic impacts than those watched when corticosteroids are managed systemically. Mild asthma: Patients requiring symptomatic bronchodilator asthma medicine on a normal basis. Moderate asthma: Patients with unsteady or declining asthma in spite of prophylactic treatment or bronchodilator alone. Severe asthma: Patients with extreme incessant asthma and those who are subordinate on systemic corticosteroids for satisfactory control of indicationsNumerous patients who are subordinate on systemic corticosteroids for satisfactory control of indications may be able to decrease altogether or kill, their prerequisite for verbal corticosteroids when they are exchanged for tall measurements

Pharmacology of Decomit Nasal Spray

Beclomethasone dipropionate produces anti-inflammatory and vasoconstrictor impacts. The instruments dependable for the anti-inflammatory activity of beclomethasone dipropionate are obscure. Corticosteroids have appeared to have a wide extent of impacts on different cell sorts (e.g., pole cells, eosinophils, neutrophils, macrophages, and lymphocytes) and arbiters (e.g., histamine, eicosanoids, leukotrienes, and cytokines) included in irritation. The coordinated relationship of these discoveries to the impacts of beclomethasone dipropionate on unfavorably susceptible rhinitis side effects isn’t known. Biopsies of nasal mucosa gotten amid clinical Severe asthma: Patients with serious persistent asthma and those who are subordinate on systemic corticosteroids for satisfactory control of side effectsNumerous patients who are subordinate on systemic corticosteroids for satisfactory control of indications may be able to diminish altogether, or dispose of, their prerequisite for verbal corticosteroids when they are exchanged for tall measurements

Administration & Dosage of Decomit Nasal Spray

Beclometasone dipropionate Inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled beclometasone dipropionate appropriate to the severity of their disease. The dose may then be adjusted until control is achieved, or reduced to the minimum effective dose according to individual response.

Adults (including the elderly): The usual starting dose is 200 micrograms twice a day. In more severe cases the starting dose may need to increase to 600 to 800 micrograms per day which may then be reduced when the patient’s asthma has stabilized. The total daily dose may be administered as two, three, or four divided doses

Children: 50 to 100 micrograms should be given two, three, or four times daily in accordance with the response. Alternatively, 100 micrograms or 200 micrograms twice daily should be given. The usual starting dose is 100 micrograms twice daily. Beclometasone 250 Inhaler is not recommended for children. Beclometasone 250 HFA Inhaler: The usual starting dose is 200 micrograms twice a day. In more severe cases the starting dose may need to increase to 600 to 800 micrograms per day which may then be reduced when the patient’s asthma has stabilized. The total daily dose may be administered as two, three, or four divided doses.

There is no need to increase the dose in patients with hepatic or renal impairment.
Take off the cap.

  1. Shake the inhaler (at least six times) vigorously before each use.
  2. If the inhaler is new or if it has not been used for a week or more, shake it well and release one puff into the air to make sure that it works.
  3. Breathe out as fully as comfortably possible & hold the inhaler upright.
  4. Place the actuator into mouth between the teeth and close the lips around the mouthpiece.
  5. While breathing deeply and slowly through the mouth, press down firmly and add fully on the canister to release medicine.
  6. Remove the inhaler from the mouth. Continue holding your breath for at least for 10 seconds or as long as it is comfortable.
  7. If the doctor has prescribed more than one inhalation per treatment, wait 1 minute between puffs (inhalations). Shake the inhaler well and repeat steps 4 to 7.
  8. After use, replace the cap on the mouthpiece. After each treatment, rinse your mouth with water.
  9. Check your technique in front of a mirror from time to time, if you see a white mist during the inhalation, you may not have closed your lips properly around the mouthpiece, or you may not be breathing in as you press the can. This indicates a failure of the technique. If this happens, repeat the procedure from step 4 carefully.

Interaction of Decomit Nasal Spray

Touchiness to any of the components. Uncommon care is essential in patients with dynamic or tranquil aspiratory tuberculosis.

Contraindications

Touchiness to any of the components. Uncommon care is essential in patients with dynamic or tranquil aspiratory tuberculosis.

Side Effect of Decomit Nasal Spray

Systemic impacts of breathed-in corticosteroids may happenespecially at tall measurements endorsed for drawn-out periods. Conceivable systemic impacts incorporate Cushing’s disorder, Cushingoid highlights, adrenal concealmentdevelopmental impediment in children and young peoplediminished bone mineral thickness, cataracts, and glaucoma.

Pregnancy & Lactation

There’s lacking prove of security in human pregnancy. Organization of corticosteroids for pregnant creatures can cause variations from the norm of fetal advancement counting cleft sense of taste and intra-uterine development retardation. The utilization of beclometasone dipropionate in moms’ breasts to bolster their babies requires that the helpful benefits of the sedate be weighed against the potential risks to the mother and infant.

Precautions & Warnings

Patients ought to be educated about the legitimate utilization of the inhaler, and their method checked, to guarantee that the medication comes to the target ranges inside the lungs. They ought to moreover be made aware that Beclometasone Inhaler should be utilized routinelyeach day, indeed when they are asymptomatic, for ideal advantage.

Therapeutic Class

Respiratory corticosteroids

Storage Conditions

Protect from light and moisture by storing below 30°C. Keep the medicine out of children’s reach.

Pharmaceutical Name of Decomit Nasal Spray

Beximco Pharmaceuticals Ltd

Generic of Decomit Nasal Spray

Beclomethasone Dipropionate